171 related articles for article (PubMed ID: 36357836)
21. Comprehensive analysis the diagnosis, malignant progression and immune infiltrate of ANXA6 in prostate cancer.
Huang B; Yang K
Genes Genomics; 2023 Sep; 45(9):1197-1209. PubMed ID: 37311953
[TBL] [Abstract][Full Text] [Related]
22. BAIAP2L2 facilitates the malignancy of prostate cancer (PCa) via VEGF and apoptosis signaling pathways.
Song Y; Zhuang G; Li J; Zhang M
Genes Genomics; 2021 Apr; 43(4):421-432. PubMed ID: 33646530
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
24. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
Liang X; Li Z; Men Q; Li Y; Li H; Chong T
Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
[TBL] [Abstract][Full Text] [Related]
25. Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma.
Che JP; Li W; Yan Y; Liu M; Wang GC; Li QY; Yang B; Yao XD; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2300-11. PubMed ID: 24228091
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.
Zeng YR; Han ZD; Wang C; Cai C; Huang YQ; Luo HW; Liu ZZ; Zhuo YJ; Dai QS; Zhao HB; Liang YX; Zhong WD
BMC Urol; 2015 Aug; 15():90. PubMed ID: 26320076
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and prognosis potential of four gene promoter hypermethylation in prostate cancer.
Li Y; Meng L; Shi T; Ren J; Deng Q
Cell Biol Int; 2021 Jan; 45(1):117-126. PubMed ID: 32991011
[TBL] [Abstract][Full Text] [Related]
28. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide gene expression analysis of a murine model of prostate cancer progression: Deciphering the roles of IL-6 and p38 MAPK as potential therapeutic targets.
Daouk R; Bahmad HF; Saleh E; Monzer A; Ballout F; Kadara H; Abou-Kheir W
PLoS One; 2020; 15(8):e0237442. PubMed ID: 32790767
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.
Shi J; Liu C; Chen C; Guo K; Tang Z; Luo Y; Chen L; Su Y; Xu K
Aging (Albany NY); 2020 Jul; 12(13):13255-13280. PubMed ID: 32645691
[TBL] [Abstract][Full Text] [Related]
31. Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer.
Lu J; Dong W; He H; Han Z; Zhuo Y; Mo R; Liang Y; Zhu J; Li R; Qu H; Zhang L; Wang S; Ma R; Jia Z; Zhong W
Int J Biol Macromol; 2018 Oct; 118(Pt A):599-609. PubMed ID: 29874556
[TBL] [Abstract][Full Text] [Related]
32. EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis.
Du TQ; Liu R; Zhang Q; Luo H; Liu Z; Sun S; Wang X
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358967
[TBL] [Abstract][Full Text] [Related]
33. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
34. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
[TBL] [Abstract][Full Text] [Related]
35. PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.
Liu H; He X; Li T; Qu Y; Xu L; Hou Y; Fu Y; Wang H
BMC Urol; 2022 Feb; 22(1):14. PubMed ID: 35109849
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of CUL4A in human prostate cancer.
Liu G; Zhu Z; Lang F; Li B; Gao D
Tumour Biol; 2015 Nov; 36(11):8553-8. PubMed ID: 26036759
[TBL] [Abstract][Full Text] [Related]
37. Promoting cell proliferation, cell cycle progression, and glycolysis: Glycometabolism-related genes act as prognostic signatures for prostate cancer.
Zhang Y; Mou Y; Liang C; Zhu S; Liu S; Shao P; Li J; Wang Z
Prostate; 2021 Feb; 81(3):157-169. PubMed ID: 33338276
[TBL] [Abstract][Full Text] [Related]
38. MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer.
Chang Y; Deng Q; Guan Z; Cheng Y; Sun Y
Mol Biotechnol; 2022 Jan; 64(1):17-24. PubMed ID: 34431044
[TBL] [Abstract][Full Text] [Related]
39. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the expression and association of retinoblastoma binding protein 6 with the JNK signaling pathway in prostate cancers.
Guan WY; Zhao S; Luo YN
Cell Biol Int; 2020 Oct; 44(10):2107-2119. PubMed ID: 32662898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]